# Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients

> **NCT01758289** · — · TERMINATED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 105 (actual)

## Conditions studied

- Chronic Kidney Disease Stage V
- Hemodialysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01758289
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** Changes in country regulation
- **Last updated:** 2014-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758289, "Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01758289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*